{"id":"NCT03976102","sponsor":"Dr. Reddy's Laboratories Limited","briefTitle":"Compare Efficacy, Safety, and Immunogenicity of Proposed Rituximab Biosimilar (DRL_RI) With MabThera® in LTB Follicular Lymphoma","officialTitle":"A Double-blind, Parallel-group, Phase III Study to Compare the Efficacy, Safety, and Immunogenicity of Proposed Rituximab Biosimilar (DRL_RI) With MabThera® in Subjects With Previously Untreated (CD)20-Positive LTB Follicular Lymphoma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-05-15","primaryCompletion":"2022-09-28","completion":"2023-02-27","firstPosted":"2019-06-05","resultsPosted":"2024-01-22","lastUpdate":"2024-01-22"},"enrollment":317,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Follicular Lymphoma"],"interventions":[{"type":"BIOLOGICAL","name":"DRL_RI (Proposed rituximab biosimilar)","otherNames":[]},{"type":"OTHER","name":"MabThera®","otherNames":[]}],"arms":[{"label":"Arm A: DRL_RI","type":"EXPERIMENTAL"},{"label":"Arm B: MabThera®","type":"ACTIVE_COMPARATOR"}],"summary":"The primary objective of the current study is to demonstrate the equivalent efficacy of rituximab (DRL\\_RI) and MabThera® in subjects with Low Tumor Burden Follicular Lymphoma (LTB-FL).\n\nAlso evaluated by Pharmacokinetic, safety, and immunogenicity assessment between a proposed biosimilar (DRL\\_RI) and the RMP, as an component of clinical study program, and collectively providing the evidence of biosimilarity.\n\nThe study will compare the safety and efficacy of DRL\\_RI vs MabThera in patients with Low Tumor Burden Follicular Lymphoma (LTB-FL). The primary objective is to establish comparative efficacy as measured by ORR up to week 28","primaryOutcome":{"measure":"Best Overall Response Rate (BORR) for Low Tumor Burden Follicular Lymphoma","timeFrame":"Month 7 (Week 28)","effectByArm":[{"arm":"Arm A: DRL_RI","deltaMin":80.2,"sd":null},{"arm":"Arm B: MabThera®","deltaMin":79.4,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":4,"countries":["United States"]},"refs":{"pmids":["40421128"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":22,"n":162},"commonTop":["COVID-19","Pruritus","Nausea","Neutropenia","Abdominal pain"]}}